Beam Therapeutics BEAM Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | -$376.74M— | —— | -$289.09M+22.0% | ||
| $22.29M+1.7% | $21.93M+9.6% | $20.01M+41.5% | $14.15M+89.9% | ||
| $94.24M-21.9% | $120.66M+22.3% | $98.65M+17.0% | $84.32M+93.5% | ||
| -$345.1M+0.6% | -$347.25M— | —— | —— | ||
| $14.95M+67.1% | $8.95M-73.5% | $33.73M-31.1% | $48.95M+4.6% | ||
| —— | $185.01M+158% | $71.84M— | —— | ||
| —— | —— | —— | —— | ||
| $478.05M+6,080% | $7.74M-97.2% | $276.45M+148% | $111.59M-85.2% | ||
| $11.51M— | —— | $199.09M— | —— | ||
| -$360.05M-1.1% | -$356.19M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Beam Therapeutics generate?
- Beam Therapeutics (BEAM) generated -$369.7M in operating cash flow over the trailing twelve months.
- What is Beam Therapeutics's free cash flow?
- After $14.1M of capital expenditures, Beam Therapeutics's free cash flow was -$383.8M over the trailing twelve months, down 6.3% year over year.
- Where does Beam Therapeutics's cash flow data come from?
- Every line is extracted from Beam Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
